ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugOrion Pharma AG
Orion Pharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Orion Pharma AG is the development, production and marketing of pharmaceuticals for human and veterinary medicine as well as pharmaceutical excipients.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered9
Neurology medicines
Neurology medicines for Parkinson’s disease and other neurological conditions; in Switzerland the portfolio includes products such as Comtan and Stalevo.
Respiratory medicines
Respiratory medicines and inhalation systems for asthma, COPD and other airway diseases; in Switzerland including Easyhaler products such as Beclo Orion Easyhaler and Salbu Orion Easyhaler.
Gynaecology medicines
Gynaecology medicines, especially hormone replacement therapies for severe menopausal symptoms; in Switzerland including products such as Divigel, Elleacnelle and Indivina.
Oncology medicines
Oncology medicines and therapies for cancer treatment; in Switzerland including products such as Leucovorin Calcium Farmos and Tamoxifen Farmos, with focus on hormone-dependent cancers.
Critical care medicines
Critical care and anaesthesia medicines for the treatment of severely ill patients; in Switzerland including products such as Dexdor and Simdax.
Rheumatology and dermatology medicines
Medicines for rheumatology and dermatology indications; in Switzerland particularly including Methotrexate ORION rheuma/derm with related risk-minimisation materials.
Pain research and development
Research and development of non-opioid pain therapies; focus areas include affecting pain signals, the immune system, and new medicines without addiction potential.
Oncology research and development
Research and development of new oncology therapies based on genetic and molecular data; includes small molecules, bispecific antibodies, antibody-drug conjugates and CAR-T cells.
Pharmacovigilance and product safety
Pharmacovigilance, reporting of adverse drug reactions, quality issues and product-related medical enquiries; includes legally required monitoring of product safety and quality.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Orion Pharma AG

Trust & reputation

ranQ Trust Score of Orion Pharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Orion Pharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Orion Pharma AG scores 92.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.82.07%
Orion Pharma AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Orion Pharma AG scores 91.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.91.44%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Orion Pharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Orion Pharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Orion Pharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Orion Pharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Orion Pharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Baarerstrasse 75
6300 Zug

At a glance

Legal form
Corporation
UID
CHE-107.308.273
Founded
1978 · 48 years
Last commercial register change
June 6, 2023
Employees
21 to 50
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ST
    SpringWorks Therapeutics Europe GmbH
    Zug
    DP
    Deciphera Pharmaceuticals (Schweiz) AG
    Zug
    TP
    Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
    Zug
    HP
    Helvion Pharma AG
    Zug
    IP
    IPSEN Pharma Schweiz GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    OS
    ORACTIVE SWISS AG
    Zug
    SP
    SGI Pharmaceuticals AG
    Zug